Clinical Trial Update: CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound [NA]

View source ↗

Summary

The CARPEUS trial update shows recruitment for evaluating carvedilol's effect on the portosystemic gradient in patients with cirrhosis-related portal hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Cirrhosis, Portal Hypertension Related to Cirrhosis | NA | Status: RECRUITING